Author

Devin S. Brandt

Access to Advanced Health Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:drug response / drug discovery· 1 Organism:multiple species· 1 Organism:rat· 1

Frequent Co-Authors

Darshan N. KasaliD· 3 shared Emily A. VoigtiD· 3 shared Julie Bakken· 3 shared Alana GerhardtiD· 2 shared Christopher Press· 2 shared Eduard H. MeliefiD· 2 shared Ethan LoiD· 2 shared Jasneet Singh· 2 shared

Activity by Year

2025-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Darshan N. KasalORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintOct 31, 2025

The ID93 + GLA-3M-052-LS vaccine candidate elicits mucosal and systemic immunogenicity and protective efficacy against Mycobacterium tuberculosis challenge in BCG-primed Collaborative Cross inbred mice

Emily A. Voigt, Anas Alsharaydeh, Darshan N. Kasal…·Christopher B. Fox

This study evaluates a TB vaccine candidate, ID93 + GLA-3M-052-LS, showing enhanced mucosal and systemic immunity and protection against Mtb in BCG-primed mice.

1 citation

mouseexperimental assay

𝕏 PostBluesky

ImmunologyInternational Journal of PharmaceuticsPeer-reviewedMay 26, 2025

A Spray Dried Replicon Vaccine Platform for Pandemic Response

Wynton D. McClary, John Z. Chen, Hui Wang…·Alana Gerhardt

This paper demonstrates the successful spray drying of a replicon-NLC vaccine against H5N1 avian influenza, maintaining stability and immunogenicity for up to 3 months at 4°C.

2 citations

mouseexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintMar 31, 2025

Development of an Intranasally- and Intramuscularly-Administrable Replicon Vaccine Efficacious Against H5N1 Influenza Virus

Wynton D. McClary, Devin S. Brandt, Madeleine F. Jennewein…·Emily A. Voigt

This paper develops a replicon vaccine against H5N1 influenza that can be administered intranasally or intramuscularly, showing efficacy in reducing morbidity and mortality in a ferret model.

1 citation

mouserat

𝕏 PostBluesky